Closed
SectorHealthcare
428.63 -1.11
24h
Min
425.19
Max
435.29
Income | 31M -42M |
|---|---|
Sales | 76M 213M |
EPS | -1.9 |
Profit margin | -19.869 |
Employees | 528 |
EBITDA | 31M -39M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +16.21% upside |
Next Earnings | 4 lis 2025 |
|---|
Market Cap | 2.8B 9.7B |
|---|---|
Previous open | 429.74 |
Previous close | 428.63 |
By Acuity
36%
64%
111 / 373 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 506.43 USD 16.21%
High 590 USD
Low 266 USD
Based on 16 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$